Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

Takeda To Manufacture 50% Of Its Dengue Vaccines In India

Summary by Ground News
Japanese drugmaker Takeda Pharmaceutical Co. announced a strategic partnership with Indian vaccine and biologics company Biological E. Ltd. The Indian partner is expected to "scale up its production capacity to potentially reach 50 million doses annually" The vaccine is currently approved in more than 30 countries, including the European Union, the United Kingdom and Brazil.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Hyderabad, IndiaHyderabad, India
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal